iMeds.se

Allopurinol Orion

Information för alternativet: Allopurinol Orion 300 Mg Tablett, visa andra alternativ
Document: Allopurinol Orion tablet ENG PL change

Package leaflet: Information for the user


Allopurinol Orion 100 mg tablets

Allopurinol Orion 300 mg tablets


allopurinol


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.


What is in this leaflet

1. What Allopurinol Orion is and what it is used for

2. What you need to know before you take Allopurinol Orion

3. How to take Allopurinol Orion

4. Possible side effects

5. How to store Allopurinol Orion

6. Contents of the pack and other information


What Allopurinol Orion is and what it is used for


Allopurinol belongs to a group of medicines called enzyme inhibitors, which act to control the speed at which special chemical changes occur in the body.


Allopurinol Orion tablets are used for the long-term, preventative treatment of gout and may be used in other conditions associated wth an excess of uric acid in the body, including kidney stones and other types of kidney disease.


Children aged under 15 years: Only Allopurinol Orion 100 mg tablets may be used for children aged under 15 years. The 300 mg tablets contain a colouring agent (Sunset Yellow FCF aluminium lake, E110) that is not recommended for use in children and adolescents.


2. What you need to know before you take Allopurinol Orion


Do not take Allopurinol Orion:


Warnings and precautions

Talk to your doctor or pharmacist before taking Allopurinol Orion tablets if you


Serious skin rashes (hypersensitivity syndrome, Stevens- Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of allopurinol. Frequently, the rash can involve ulcers of the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These serious skin rashes are often preceded by influenza-like symptoms fever, headache, body ache (flu-like symptoms). The rash may progress to widespread blistering and peeling of the skin. These serious skin reactions can be more common in people of Han Chinese or Thai origin. If you develop a rash or these skin symptoms, stop taking allopurinol and contact your doctor immediately.


If you are not sure if any of the following applies to you, talk to your doctor or pharmacist before taking allopurinol.


Other medicines and Allopurinol Orion tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without prescription.


Tell your doctor before you start to take this medicine if you are taking:

6‑mercaptopurine (used to treat blood cancer)

medicines to treat aggressive tumours, such as

Your doctor will monitor your blood counts frequently.

The risk of skin reactions can be raised, especially if your kidney function is chronically reduced.


Pregnancy, breast-feeding and fertility

If you are pregnant, planning to become pregnant or are breast-feeding, ask your doctor or pharmacist for advice before taking this medicine.


Driving and using machines

Allopurinol Orion tablets can cause dizziness, drowsiness, and can affect your coordination. If you are affected, do not drive, operate machinery or participate in dangerous activities.


Allopurinol Orion 100 mg and 300 mg tablets contain lactose and Allopurinol Orion 300 mg tablets contain colouring agent Sunset Yellow FCF aluminium lake (E110)

Allopurinol Orion 100 mg and 300 mg tablets contain lactose. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product.


Allopurinol Orion 300 mg tablets contains the colouring agent Sunset Yellow FCF aluminium lake (E110) which may cause allergic reaction. The 300 mg tablets are not recommended for use in children aged under 15 years.


3. How to take Allopurinol Orion


Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


The tablet can be divided into equal doses. The tablets should be swallowed with a drink of water. You should take your tablets after a meal.


The recommended doses are:


Adults, adolescents (15–18 years), elderly

Starting dose: 100–300 mg/day.

When you start your treatment, your doctor may also prescribe an anti-inflammatory medicine or colchicine for a month or more, to prevent attacks of gouty arthritis.


Your dose of allopurinol may be adjusted depending on the severity of the condition. The maintenance dose is:


Your dose may also be altered by your doctor if you have reduced kidney and liver function, particularly if you are elderly.


If the daily dose exceeds 300 mg/day and you are suffering from gastrointestinal side effects such as nausea or vomiting (see section 4), your doctor may prescribe allopurinol in divided doses to reduce these effects.


If you have a serious kidney problem

If you have dialysis two or three times a week, your doctor may prescribe a dose of 300 or 400 mg which is to be taken straight after your dialysis.


Only Allopurinol 100 mg tablets:


Children aged under 15 years

100–400 mg/day.

Treatment may be started together with an anti-inflammatory medicine or colchicine, and the dose adjusted if you have reduced kidney and liver function, or divided to reduce gastrointestinal side effects, as for Adults above.


If you take more Allopurinol Orion than you should

If you (or someone else) swallow a lot of the tablets all together or if you think a child has swallowed any of the tablets, contact your nearest hospital casualty department or your doctor immediately.


An overdose is likely to cause side effects including nausea, vomiting, diarrhoea, or dizziness.


Please take this package leaflet, any remaining tablets, and the container with you to the hospital or doctor so that they know which tablets were consumed.


If you forget to take Allopurinol Orion

If you forget to take a tablet, take one as soon as you remember, unless it is near1y time to take the next one. Do not take a double dose to make up for a forgotten dose. Take the remaining doses at the correct time.


If you stop taking Allopurinol Orion

You should continue to take these tablets for as long as your doctor tells you to. Do not stop taking your medicine without talking to your doctor first.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Usually, allopurinol treatment causes side effects only rarely, and any occurring side effects are mild.


Stop taking Allopurinol Orion and contact a doctor immediately if you experience

an unexpected skin reaction (possibly in association with fever, swollen glands, joint pain, unusual blistering or bleeding, kidney problems or a sudden onset of fits).

Skin rashes are the most common side effect with allopurinol (affecting less than one person in 10 but more than one person in 100).


Rare side effects(affects less than 1 in 1,000 people)


Allergic reactions (affects less than 1 in 10,000 people)

If you have an allergic reaction, stop taking allopurinol and see a doctor straight away. The signs may include:

Do not take any more tablets unless your doctor tells you to do so.


If you experience any of the following while you are taking Allopurinol Orion, stop taking your tablets and tell your doctor as soon as possible:


Uncommon side effects (affecting less than one person in 100 but more than one person in 1,000):


Rare side effects (affecting less than one person in 1,000 but more than one person in 10,000):


Very rare side effects (affecting less than one person in 10,000):


You may occasionally feel sick, but this can usually be avoided by taking allopurinol after meals. Tell your doctor if this problem persists.


Occasionally, allopurinol may affect your blood or lymphatic system. These effects have usually occurred in people with liver or kidney problems. Tell your doctor as soon as you can if you notice that you are bruising more easily than usual, or if you develop a sore throat or other signs of an infection.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist.This includes any possible side effects not listed in this leaflet.You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine.


[*For the printed material, please refer to the guidance of the annotated QRD template.]


5. How to store Allopurinol Orion


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton and blister after {abbreviation used for expiry date}. The expiry date refers to the last day of that month.


This medicinal product does not require any special storage conditions.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Allopurinol Orion contains



What Allopurinol Orion looks like and contents of the pack


Allopurinol Orion 100 mg tablets are white to off-white-coloured, round, biconvex uncoated tablets with ‘AL’ & ‘100’ separated by breakline on one side and plain on the other side.


Allopurinol Orion 300 mg tablets are peach-coloured, round, biconvex uncoated tablets with ‘AL’ & ‘300’ separated by breakline on one side and plain on the other side.


Allopurinol Orion 100 mg tablets are available in packs of 50 and 100.

Allopurinol Orion 300 mg tablets are available in packs of 30 and 100.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


Orion Corporation

Orionintie 1

FI‑02200 Espoo

Finland


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

[To be completed nationally]


This leaflet was last revised in 2014 12 07


6